Filing Details
- Accession Number:
- 0001209191-21-015846
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-02 16:06:54
- Reporting Period:
- 2021-02-26
- Accepted Time:
- 2021-03-02 16:06:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 924717 | Surmodics Inc | SRDX | Surgical & Medical Instruments & Apparatus (3841) | 411356149 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1183157 | E Susan Knight | 9154 Breckenridge Lane Eden Prairie MN 55437 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-26 | 5,576 | $21.31 | 34,290 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-26 | 5,576 | $52.36 | 28,714 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-02-26 | 5,576 | $0.00 | 5,576 | $21.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-12-03 | No | 4 | M | Direct |
Footnotes
- Reflects the weighted average price of 5,576 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on February 26, 2021 with sale prices ranging from $51.93 to $52.69 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The amount beneficially owned includes 11,721 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
- Fully vested.
Billionaire Hedge Funds
